help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, B. R.
Right arrow Articles by Edwards, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, B. R.
Right arrow Articles by Edwards, C. R.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 3155-3159, Copyright © 1995 by Endocrine Society

ARTICLES

Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation

BR Walker, AA Connacher, RM Lindsay, DJ Webb and CR Edwards
University of Edinburgh, Department of Medicine, Western General Hospital, Scotland.

In the kidney, conversion of cortisol to cortisone by the enzyme 11 beta-hydroxysteroid dehydrogenase protects mineralocorticoid receptors from cortisol. In the liver, a different isoform of the enzyme favors 11 beta-reductase conversion of cortisone to cortisol. We have tested the hypothesis that hepatic 11 beta-reductase enhances glucocorticoid receptor activation in the liver by inhibiting the enzyme with carbenoxolone and observing effects on insulin sensitivity. Seven healthy males took part in a double blind randomized cross-over study in which oral carbenoxolone (100 mg every 8 h) or placebo was administered for 7 days. Euglycemic hyperinsulinemic clamp studies were then performed, including measurement of forearm glucose uptake. Carbenoxolone increased whole body insulin sensitivity (M values for dextrose infusion rates, 41.1 +/- 2.4 mumol/kg.min for placebo vs. 44.6 +/- 2.3 for carbenoxolone; P < 0.03), but had no effect on forearm insulin sensitivity. We infer that carbenoxolone, by inhibiting hepatic 11 beta-reductase and reducing intrahepatic cortisol concentration, increases hepatic insulin sensitivity and decreases glucose production. Thus, plasma cortisone provides an inactive pool that can be converted to active glucocorticoids at sites where 11 beta-reductase is expressed, abnormal hepatic 11 beta-reductase activity might be important in syndromes of insulin resistance, and manipulation of hepatic 11 beta-reductase may be useful in treating insulin resistance.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
D. P Macfarlane, S. Forbes, and B. R Walker
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
J. Endocrinol., May 1, 2008; 197(2): 189 - 204.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
I J Bujalska, L L Gathercole, J W Tomlinson, C Darimont, J Ermolieff, A N Fanjul, P A Rejto, and P M Stewart
A novel selective 11{beta}-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
J. Endocrinol., May 1, 2008; 197(2): 297 - 307.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Courtney, P. M. Stewart, M. Toh, M.-N. Ndongo, R. A. Calle, and B. Hirshberg
Modulation of 11{beta}-Hydroxysteroid Dehydrogenase (11{beta}HSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11{beta}HSD1 Inhibitor
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 550 - 556.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. G. Bhat, N. Hosea, A. Fanjul, J. Herrera, J. Chapman, F. Thalacker, P. M. Stewart, and P. A. Rejto
Demonstration of Proof of Mechanism and Pharmacokinetics and Pharmacodynamic Relationship with 4'-Cyano-biphenyl-4-sulfonic Acid (6-Amino-pyridin-2-yl)-amide (PF-915275), an Inhibitor of 11 -Hydroxysteroid Dehydrogenase Type 1, in Cynomolgus Monkeys
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 299 - 305.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. M. Nuotio-Antar, D. L. Hachey, and A. H. Hasty
Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1517 - E1528.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, M. Sherlock, B. Hughes, S. V. Hughes, F. Kilvington, W. Bartlett, R. Courtney, P. Rejto, W. Carley, and P. M. Stewart
Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 857 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. Qi and B. Rodrigues
Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
B. R WALKER and R. ANDREW
Tissue Production of Cortisol by 11beta-Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 165 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Gambineri, V. Vicennati, S. Genghini, F. Tomassoni, U. Pagotto, R. Pasquali, and B. R. Walker
Genetic Variation in 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Predicts Adrenal Hyperandrogenism among Lean Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2295 - 2302.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Bruley, V. Lyons, A. G. F. Worsley, M. D. Wilde, G. D. Darlington, N. M. Morton, J. R. Seckl, and K. E. Chapman
A Novel Promoter for the 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Gene Is Active in Lung and Is C/EBP{alpha} Independent
Endocrinology, June 1, 2006; 147(6): 2879 - 2885.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. M. Morton, V. Densmore, M. Wamil, L. Ramage, K. Nichol, L. Bunger, J. R. Seckl, and C. J. Kenyon
A Polygenic Model of the Metabolic Syndrome With Reduced Circulating and Intra-Adipose Glucocorticoid Action
Diabetes, December 1, 2005; 54(12): 3371 - 3378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. G. Gnanalingham, A. Mostyn, M. E. Symonds, and T. Stephenson
Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1407 - R1415.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Andrew, J. Westerbacka, J. Wahren, H. Yki-Jarvinen, and B. R. Walker
The Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Diabetes, May 1, 2005; 54(5): 1364 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. C. Sandeep, R. Andrew, N. Z.M. Homer, R. C. Andrews, K. Smith, and B. R. Walker
Increased In Vivo Regeneration of Cortisol in Adipose Tissue in Human Obesity and Effects of the 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Carbenoxolone
Diabetes, March 1, 2005; 54(3): 872 - 879.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Liu, Y. Nakagawa, Y. Wang, R. Sakurai, P. V. Tripathi, K. Lutfy, and T. C. Friedman
Increased Glucocorticoid Receptor and 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Hepatocytes May Contribute to the Phenotype of Type 2 Diabetes in db/db Mice
Diabetes, January 1, 2005; 54(1): 32 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. P. Girod and D. J. Brotman
Does altered glucocorticoid homeostasis increase cardiovascular risk?
Cardiovasc Res, November 1, 2004; 64(2): 217 - 226.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. W. Franks, W. C. Knowler, S. Nair, J. Koska, Y.-H. Lee, R. S. Lindsay, B. R. Walker, H. C. Looker, P. A. Permana, P. A. Tataranni, et al.
Interaction Between an 11{beta}HSD1 Gene Variant and Birth Era Modifies the Risk of Hypertension in Pima Indians
Hypertension, November 1, 2004; 44(5): 681 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Valsamakis, A. Anwar, J. W. Tomlinson, C. H. L. Shackleton, P. G. McTernan, R. Chetty, P. J. Wood, A. K. Banerjee, G. Holder, A. H. Barnett, et al.
11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity in Lean and Obese Males with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4755 - 4761.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, C. M. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza
Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisone to Cortisol Via the 11-{beta} Hydroxysteroid Dehydrogenase (11{beta}-HSD) Type 1 Pathway
Diabetes, August 1, 2004; 53(8): 2051 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. E. Kershaw and J. S. Flier
Adipose Tissue as an Endocrine Organ
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2548 - 2556.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, J. S. Moore, P. M. S. Clark, G. Holder, L. Shakespeare, and P. M. Stewart
Weight Loss Increases 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2711 - 2716.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. C. Sandeep, J. L. W. Yau, A. M. J. MacLullich, J. Noble, I. J. Deary, B. R. Walker, and J. R. Seckl
From The Cover: 11{beta}-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics
PNAS, April 27, 2004; 101(17): 6734 - 6739.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. M. Morton, J. M. Paterson, H. Masuzaki, M. C. Holmes, B. Staels, C. Fievet, B. R. Walker, J. S. Flier, J. J. Mullins, and J. R. Seckl
Novel Adipose Tissue-Mediated Resistance to Diet-Induced Visceral Obesity in 11{beta}-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice
Diabetes, April 1, 2004; 53(4): 931 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
P. Alberts, C. Nilsson, G. Selen, L. O. M. Engblom, N. H. M. Edling, S. Norling, G. Klingstrom, C. Larsson, M. Forsgren, M. Ashkzari, et al.
Selective Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
Endocrinology, November 1, 2003; 144(11): 4755 - 4762.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Westerbacka, H. Yki-Jarvinen, S. Vehkavaara, A.-M. Hakkinen, R. Andrew, D. J. Wake, J. R. Seckl, and B. R. Walker
Body Fat Distribution and Cortisol Metabolism in Healthy Men: Enhanced 5{beta}-Reductase and Lower Cortisol/Cortisone Metabolite Ratios in Men with Fatty Liver
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4924 - 4931.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Wake, E. Rask, D. E. W. Livingstone, S. Soderberg, T. Olsson, and B. R. Walker
Local and Systemic Impact of Transcriptional Up-Regulation of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue in Human Obesity
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3983 - 3988.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, N. Crabtree, P. M. S. Clark, G. Holder, A. A. Toogood, C. H. L. Shackleton, and P. M. Stewart
Low-Dose Growth Hormone Inhibits 11{beta}-Hydroxysteroid Dehydrogenase Type 1 but Has No Effect upon Fat Mass in Patients with Simple Obesity
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2113 - 2118.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. E. W. Livingstone and B. R. Walker
Is 11beta -Hydroxysteroid Dehydrogenase Type 1 a Therapeutic Target? Effects of Carbenoxolone in Lean and Obese Zucker Rats
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 167 - 172.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. C. Andrews, O. Rooyackers, and B. R. Walker
Effects of the 11{beta}-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 285 - 291.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker
Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Draper, S. M. Echwald, G. G. Lavery, E. A. Walker, R. Fraser, E. Davies, T. I. A. Sorensen, A. Astrup, J. Adamski, M. Hewison, et al.
Association Studies between Microsatellite Markers within the Gene Encoding Human 11{beta}-Hydroxysteroid Dehydrogenase Type 1 and Body Mass Index, Waist to Hip Ratio, and Glucocorticoid Metabolism
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4984 - 4990.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. M. Stulnig, U. Oppermann, K. R. Steffensen, G. U. Schuster, and J.-A. Gustafsson
Liver X Receptors Downregulate 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
Diabetes, August 1, 2002; 51(8): 2426 - 2433.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I.W. Phillips, and C. D. Byrne
Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome
Diabetes, April 1, 2002; 51(4): 1066 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R.J Irving, B.R Walker, J.P Noon, G.C.M Watt, D.J Webb, and A.C Shore
Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health
Cardiovasc Res, January 1, 2002; 53(1): 271 - 276.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Johansson, R. Andrew, H. Forsberg, K. Cederquist, B. R. Walker, and T. Olsson
Glucocorticoid Metabolism and Adrenocortical Reactivity to ACTH in Myotonic Dystrophy
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4276 - 4283.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. J. Trainer, W. M. Drake, L. A. Perry, N. F. Taylor, G. M. Besser, and J. P. Monson
Modulation of Cortisol Metabolism by the Growth Hormone Receptor Antagonist Pegvisomant in Patients with Acromegaly
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2989 - 2992.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
R.J. Irving, J.P. Noon, G.C.M. Watt, D.J. Webb, and B.R. Walker
Activation of the endothelin system in insulin resistance
QJM, June 1, 2001; 94(6): 321 - 326.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. B. Whorwood, S. J. Donovan, P. J. Wood, and D. I. W. Phillips
Regulation of Glucocorticoid Receptor {{alpha}} and {beta} Isoforms and Type I 11{beta}-Hydroxysteroid Dehydrogenase Expression in Human Skeletal Muscle Cells: A Key Role in the Pathogenesis of Insulin Resistance?
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2296 - 2308.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
J. R. Seckl and B. R. Walker
Minireview: 11{beta}-Hydroxysteroid Dehydrogenase Type 1-- A Tissue-Specific Amplifier of Glucocorticoid Action
Endocrinology, April 1, 2001; 142(4): 1371 - 1376.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
P. S. Brereton, R. R. van Driel, F. b. H. Suhaimi, K. Koyama, R. Dilley, and Z. Krozowski
Light and Electron Microscopy Localization of the 11{beta}-Hydroxysteroid Dehydrogenase Type I Enzyme in the Rat
Endocrinology, April 1, 2001; 142(4): 1644 - 1651.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. L. W. Yau, J. Noble, C. J. Kenyon, C. Hibberd, Y. Kotelevtsev, J. J. Mullins, and J. R. Seckl
Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments
PNAS, March 22, 2001; (2001) 71562698.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. S. Moore, J. P. Monson, G. Kaltsas, P. Putignano, P. J. Wood, M. C. Sheppard, G. M. Besser, N. F. Taylor, and P. M. Stewart
Modulation of 11{beta}-Hydroxysteroid Dehydrogenase Isozymes by Growth Hormone and Insulin-Like Growth Factor: In Vivo and In Vitro Studies
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4172 - 4177.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Jamieson, A. M. Wallace, R. Andrew, B. S. Nunez, B. R. Walker, R. Fraser, P. C. White, and J. M. C. Connell
Apparent Cortisone Reductase Deficiency: A Functional Defect in 11{beta}-Hydroxysteroid Dehydrogenase Type 1
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3570 - 3574.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. J. Finken, R. C. Andrews, R. Andrew, and B. R. Walker
Cortisol Metabolism in Healthy Young Adults: Sexual Dimorphism in Activities of A-Ring Reductases, but not 11{beta}-Hydroxysteroid Dehydrogenases
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3316 - 3321.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Nordenström, C. Marcus, M. Axelson, A. Wedell, and E. M. Ritzén
Failure of Cortisone Acetate Treatment in Congenital Adrenal Hyperplasia because of Defective 11{beta}-Hydroxysteroid Dehydrogenase Reductase Activity
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1210 - 1213.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. M. Stewart, A. Boulton, S. Kumar, P. M. S. Clark, and C. H. L. Shackleton
Cortisol Metabolism in Human Obesity: Impaired Cortisone->Cortisol Conversion in Subjects with Central Adiposity
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1022 - 1027.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Panarelli, C. D. Holloway, R. Fraser, J. M. C. Connell, M. C. Ingram, N. H. Anderson, and C. J. Kenyon
Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human Subjects
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1846 - 1852.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
P. J. Burton, Z. S. Krozowski, and B. J. Waddell
Immunolocalization of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Rat Uterus: Variation Across the Estrous Cycle and Regulation by Estrogen and Progesterone
Endocrinology, January 1, 1998; 139(1): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Kotelevtsev, M. C. Holmes, A. Burchell, P. M. Houston, D. Schmoll, P. Jamieson, R. Best, R. Brown, C. R. W. Edwards, J. R. Seckl, et al.
11beta -Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
PNAS, December 23, 1997; 94(26): 14924 - 14929.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R.-S. Ge, D. O. Hardy, J. F. Catterall, and M. P. Hardy
Developmental Changes in Glucocorticoid Receptor and 11{beta}-Hydroxysteroid Dehydrogenase Oxidative and Reductive Activities in Rat Leydig Cells
Endocrinology, December 1, 1997; 138(12): 5089 - 5095.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R.-S. Ge, H.-B. Gao, V. L. Nacharaju, G. L. Gunsalus, and M. P. Hardy
Identification of a Kinetically Distinct Activity of 11{beta}-Hydroxysteroid Dehydrogenase in Rat Leydig Cells
Endocrinology, June 1, 1997; 138(6): 2435 - 2442.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
P. C. White, T. Mune, and A. K. Agarwal
11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
Endocr. Rev., February 1, 1997; 18(1): 135 - 156.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
B. Davani, A. Khan, M. Hult, E. Martensson, S. Okret, S. Efendic, H. Jornvall, and U. C. T. Oppermann
Type 1 11beta -Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets
J. Biol. Chem., November 3, 2000; 275(45): 34841 - 34844.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. J. S. Williams, V. Lyons, I. MacLeod, V. Rajan, G. J. Darlington, V. Poli, J. R. Seckl, and K. E. Chapman
C/EBP Regulates Hepatic Transcription of 11beta -Hydroxysteroid Dehydrogenase Type 1. A NOVEL MECHANISM FOR CROSS-TALK BETWEEN THE C/EBP AND GLUCOCORTICOID SIGNALING PATHWAYS
J. Biol. Chem., September 22, 2000; 275(39): 30232 - 30239.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Berger, M. Tanen, A. Elbrecht, A. Hermanowski-Vosatka, D. E. Moller, S. D. Wright, and R. Thieringer
Peroxisome Proliferator-activated Receptor-gamma Ligands Inhibit Adipocyte 11beta -Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
J. Biol. Chem., April 13, 2001; 276(16): 12629 - 12635.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. A. Walker, A. M. Clark, M. Hewison, J. P. Ride, and P. M. Stewart
Functional Expression, Characterization, and Purification of the Catalytic Domain of Human 11-beta -Hydroxysteroid Dehydrogenase Type 1
J. Biol. Chem., June 8, 2001; 276(24): 21343 - 21350.
[Abstract] [Full Text] [PDF]